...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: a $6 sell order drops ZEN 96% !

"What matters is "a royalty or partnership deal"  for "ZHCLF" when we are not on a proper exchange that provides us with stock liquidity as we see fit."

Hopefully Don isn't feeding this same logic 10'years from now. What "matters" to me is a real stock exchange now! It's been over a decade of this,  what "really matters" A real exchange could actually help zenith to raise money at higher levels compared to what's taking place now. 

Share
New Message
Please login to post a reply